PKTX
ProtoKinetix, Incorporated [PKTX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PKTX Stock Summary
Top 10 Correlated Stocks
PKTX
In the News
PKTX Financial details
Company Rating
-
Market Cap
5.27M
Income
-415.48K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
29 Apr 2024
P/E
-7.91
Forward P/E
-
PEG
0.96
P/S
-
P/B
16
P/C
-
P/FCF
-13.17
Quick Ratio
0.99
Current Ratio
1.07
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-80.65%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
50%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-197%
ROE
-208%
ROC
-2%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0101-0.03
52W High
-
52W Low
-
RSI
60.71
Rel Volume
0.26
Avg Volume
97.82K
Volume
25K
Perf Week
29.63%
Perf Month
35.92%
Perf Quarter
12.18%
Perf Half Y
40%
-
-
-
-
Beta
-0.13
-
-
Volatility
0%, 0%
Prev Close
9.2%
Price
0.014
Change
35.92%
Company Profile
- Volume Average 97.82K
- Market Capitalization 5.27M
- CEO Mr. Clarence Edward Smith
- Headquarters Marietta,OH,US
- IPO Date 2002-04-22
-
Website
https://www.protokinetix.com 
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.
